臨牀消化器内科 Vol.32 No.5(1-6)


特集名 肝疾患と栄養・サルコペニア
題名 肝疾患とサルコペニア(6)肝移植・肝切除と栄養・サルコペニア
発刊年月 2017年 05月
著者 海道 利実 京都大学大学院医学研究科肝胆膵移植外科
著者 濱口 雄平 京都大学大学院医学研究科肝胆膵移植外科
著者 奧村 晋也 京都大学大学院医学研究科肝胆膵移植外科
著者 小林 淳志 京都大学大学院医学研究科肝胆膵移植外科
著者 白井 久也 京都大学大学院医学研究科肝胆膵移植外科
著者 上本 伸二 京都大学大学院医学研究科肝胆膵移植外科
【 要旨 】 肝移植患者の多くは代償性肝硬変を有しており,浮腫や腹水による活動性の低下,低栄養,肝不全,高度侵襲と二次性サルコペニアのカテゴリーに当てはまる.一方,肝癌患者も高齢化しており,肝癌患者の多くは,一次性サルコペニアと慢性肝炎に伴う低栄養や癌に起因する二次性サルコペニアを合併している.したがって,両者とも術前サルコペニア評価と周術期栄養管理が大切である.肝移植,肝癌肝切除のいずれにおいても,術前サルコペニアは予後不良因子であった.肝移植患者においては,サルコペニアを考慮した移植適応により予後が向上した.術後,中長期的なリハビリ・栄養療法が,QOLの改善のみならず,予後向上に重要である.
Theme The Impact of Sarcopenia and Nutrition on Liver Diseases
Title Nutrition and Sarcopenia in Liver Transplantation and Resection
Author Toshimi Kaido Division of Hepato‒Biliary‒Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University
Author Yuhei Hamaguchi Division of Hepato‒Biliary‒Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University
Author Shinya Okumura Division of Hepato‒Biliary‒Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University
Author Atsushi Kobayashi Division of Hepato‒Biliary‒Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University
Author Hisaya Shirai Division of Hepato‒Biliary‒Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University
Author Shinji Uemoto Division of Hepato‒Biliary‒Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University
[ Summary ] Most patients undergoing liver transplantation (LT) or liver resection for hepatocellular carcinoma (HCC) meet the criteria of sarcopenia and require perioperative nutritional treatment due to protein‒energy malnutrition. In such patients, low skeletal muscle mass and low muscle quality were independent risk factors for poor survival. However, patients who received perioperative nutritional therapy including preoperative branched‒chain amino acids and postoperative early enteral nutrition had significantly better survival than those who did not. Accordingly, in 2013, we modified our indication criteria for LT considering sarcopenia. Short‒term survival after LT has dramatically improved. as a result. Skeletal muscle mass worsened after living‒donor LT and did not recover to preoperative levels until 1 year postoperative. In contrast, hand‒grip strength recovered to preoperative levels at 6 months postoperative. Low muscle quality also plays an important role in HCC recurrence after liver resection. Moreover, in patients with normal muscle quality postoperative, muscle quality worsening was an independent risk factor for HCC recurrence. Taken together, postoperative mid‒ or long‒term nutritional and rehabilitation interventions are needed to improve both patient survival and quality of life.
戻る